Smith & Nephew PLC
LSE:SN

Watchlist Manager
Smith & Nephew PLC Logo
Smith & Nephew PLC
LSE:SN
Watchlist
Price: 1 246.5 GBX 0.24%
Market Cap: £10.6B

Profitability Summary

Smith & Nephew PLC's profitability score is 53/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

53/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

53/100
Profitability
Score
53/100
Profitability
Score

Margins

Earnings Waterfall
Smith & Nephew PLC

Margins Comparison
Smith & Nephew PLC Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
UK
Smith & Nephew PLC
LSE:SN
10.7B GBP
Loading...
Loading...
Loading...
US
Abbott Laboratories
NYSE:ABT
191.5B USD
Loading...
Loading...
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
175B USD
Loading...
Loading...
Loading...
US
Stryker Corp
NYSE:SYK
132.3B USD
Loading...
Loading...
Loading...
IE
Medtronic PLC
NYSE:MDT
114.2B USD
Loading...
Loading...
Loading...
US
Boston Scientific Corp
NYSE:BSX
103.3B USD
Loading...
Loading...
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
44.3B EUR
Loading...
Loading...
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49.4B USD
Loading...
Loading...
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
47.9B USD
Loading...
Loading...
Loading...
US
Becton Dickinson and Co
NYSE:BDX
46.5B USD
Loading...
Loading...
Loading...
US
Resmed Inc
NYSE:RMD
35B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Smith & Nephew PLC Competitors

Country Company Market Cap ROE ROA ROCE ROIC
UK
Smith & Nephew PLC
LSE:SN
10.7B GBP
Loading...
Loading...
Loading...
Loading...
US
Abbott Laboratories
NYSE:ABT
191.5B USD
Loading...
Loading...
Loading...
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
175B USD
Loading...
Loading...
Loading...
Loading...
US
Stryker Corp
NYSE:SYK
132.3B USD
Loading...
Loading...
Loading...
Loading...
IE
Medtronic PLC
NYSE:MDT
114.2B USD
Loading...
Loading...
Loading...
Loading...
US
Boston Scientific Corp
NYSE:BSX
103.3B USD
Loading...
Loading...
Loading...
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
44.3B EUR
Loading...
Loading...
Loading...
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49.4B USD
Loading...
Loading...
Loading...
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
47.9B USD
Loading...
Loading...
Loading...
Loading...
US
Becton Dickinson and Co
NYSE:BDX
46.5B USD
Loading...
Loading...
Loading...
Loading...
US
Resmed Inc
NYSE:RMD
35B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Smith & Nephew PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett